| Schedule of Redeemable Noncontrolling Interest |
A summary of the Company’s redeemable noncontrolling interests on its consolidated balance sheets is set forth below: | | | | | | | | | | | | | | | | | | | | | | | | | At December 31, | 2025 | | 2024 | | | Redeemable noncontrolling interest - DaVinci | $ | 3,701,637 | | | $ | 3,061,708 | | | | Redeemable noncontrolling interest - Medici | 1,398,166 | | | 1,646,745 | | | | Redeemable noncontrolling interest - Vermeer | 1,922,431 | | | 1,799,857 | | | | Redeemable noncontrolling interest - Fontana | 579,858 | | | 469,439 | | | | Redeemable noncontrolling interests | $ | 7,602,092 | | | $ | 6,977,749 | | | | | | | | |
A summary of the Company’s redeemable noncontrolling interests on its consolidated statements of operations is set forth below: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Year ended December 31, | 2025 | | 2024 | | 2023 | | | Redeemable noncontrolling interest - DaVinci | $ | 596,851 | | | $ | 627,055 | | | $ | 545,812 | | | | Redeemable noncontrolling interest - Medici | 162,676 | | | 202,941 | | | 239,250 | | | | Redeemable noncontrolling interest - Vermeer | 122,574 | | | 244,560 | | | 239,457 | | | | Redeemable noncontrolling interest - Fontana | 53,308 | | | 15,616 | | | 34,476 | | | | Net income (loss) attributable to redeemable noncontrolling interests | $ | 935,409 | | | $ | 1,090,172 | | | $ | 1,058,995 | | | | | | | | | | |
The activity in redeemable noncontrolling interest – DaVinci is detailed in the table below: | | | | | | | | | | | | | | | | | | | | | | | | | Year ended December 31, | 2025 | | 2024 | | | Beginning balance | $ | 3,061,708 | | | $ | 2,541,482 | | | | Redemption of shares from redeemable noncontrolling interests | (26,929) | | | (406,849) | | | | Sale of shares to redeemable noncontrolling interests, net of adjustments | 70,007 | | | 300,020 | | | | | | | | | | Net income (loss) attributable to redeemable noncontrolling interest | 596,851 | | | 627,055 | | | | | | | | | | Ending balance | $ | 3,701,637 | | | $ | 3,061,708 | | | | | | | | |
The activity in redeemable noncontrolling interest – Medici is detailed in the table below: | | | | | | | | | | | | | | | | | | | | | | | | | Year ended December 31, | 2025 | | 2024 | | | Beginning balance | $ | 1,646,745 | | | $ | 1,650,229 | | | | Redemption of shares from redeemable noncontrolling interests, net of adjustments | (604,392) | | | (406,644) | | | | Sale of shares to redeemable noncontrolling interests | 208,451 | | | 200,219 | | | | Net income (loss) attributable to redeemable noncontrolling interest | 162,676 | | | 202,941 | | | | Dividends on common shares | (15,314) | | | — | | | | | | | | | | Ending balance | $ | 1,398,166 | | | $ | 1,646,745 | | | | | | | | |
The activity in redeemable noncontrolling interest – Vermeer is detailed in the table below: | | | | | | | | | | | | | | | | | | | | | | | | | Year ended December 31, | 2025 | | 2024 | | | Beginning balance | $ | 1,799,857 | | | $ | 1,555,297 | | | | Dividends on common shares | — | | | (175,000) | | | | Sale of shares to redeemable noncontrolling interest | — | | | 175,000 | | | | | | | | | | Net income (loss) attributable to redeemable noncontrolling interest | 122,574 | | | 244,560 | | | | | | | | | | Ending balance | $ | 1,922,431 | | | $ | 1,799,857 | | | | | | | | |
The activity in redeemable noncontrolling interest – Fontana is detailed in the table below: | | | | | | | | | | | | | | | | | | | | | | | | | Year ended December 31, | 2025 | | 2024 | | | Beginning balance | $ | 469,439 | | | $ | 353,823 | | | | Redemption of shares from redeemable noncontrolling interest | (72,044) | | | — | | | | Sale of limited partner interest to redeemable noncontrolling interest | 129,155 | | | 100,000 | | | | | | | | | | Net income (loss) attributable to redeemable noncontrolling interest | 53,308 | | | 15,616 | | | | | | | | | | Ending balance | $ | 579,858 | | | $ | 469,439 | | | | | | | | |
|